Response to: Aspirin for patients after TIPS. An old dog with new tricks?
- PMID: 35904749
- PMCID: PMC9525396
- DOI: 10.1007/s12072-022-10394-9
Response to: Aspirin for patients after TIPS. An old dog with new tricks?
Conflict of interest statement
JT, speaking and consulting fees: Gore, Bayer, Alexion, MSD, Gilead, Intercept, Norgine, Grifols, Versantis, and Martin Pharmaceutical. DB: Consultant: Bayer Healthcare, Boston Scientific, Shionogi. Lectures: Falk Foundation. All other authors declare no conflict of interest.
Comment on
-
Aspirin for patients after TIPS: an old dog with new tricks?Hepatol Int. 2022 Oct;16(5):1244-1245. doi: 10.1007/s12072-022-10383-y. Epub 2022 Jun 29. Hepatol Int. 2022. PMID: 35767174 No abstract available.
References
-
- Chang WH, Mueller SH, Tan YY, et al. Antithrombotic therapy in patients with liver disease: population-based insights on variations in prescribing trends, adherence, persistence and impact on stroke and bleeding. Lancet Reg Heal Eur. 2021;10:100222. doi: 10.1016/j.lanepe.2021.100222. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources